Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

BP809

Cisplatin

British Pharmacopoeia (BP) Reference Standard

Synonym(s):

cis-Diammineplatinum(II) dichloride, cis-Dichlorodiammine platinum(II), cis-Platinum(II) diammine dichloride, Cisplatin

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
Pt(NH3)2Cl2
CAS Number:
15663-27-1
Molecular Weight:
300.05
EC Number:
239-733-8
MDL number:
MFCD00011623
UNSPSC Code:
41116107
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

cisplatin

form

solid

shelf life

limited shelf life, expiry date on the label

manufacturer/tradename

BP

mp

270 °C (lit.)

application(s)

pharmaceutical
pharmaceutical small molecule

format

neat

storage temp.

2-8°C

SMILES string

N.N.Cl[Pt]Cl

InChI

1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2

InChI key

LXZZYRPGZAFOLE-UHFFFAOYSA-L

Looking for similar products? Visit Product Comparison Guide

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Cisplatin BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:
  • Cisplatin Injection

    • Biochem/physiol Actions

    Potent platinum-based antineoplastic agent. Forms cytotoxic adducts with the DNA dinucleotide d(pGpG), inducing intrastrand cross-links.

    Packaging

    Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

    Other Notes

    Sales restrictions may apply.

    related product

    Product No.
    Description
    Pricing

    C2210000

    Cisplatin, European Pharmacopoeia (EP) Reference Standard

    Y0001019

    Cisplatin impurity B, European Pharmacopoeia (EP) Reference Standard

    Y0001018

    Cisplatin impurity A, European Pharmacopoeia (EP) Reference Standard

    1551300

    Potassium Trichloroammineplatinate, United States Pharmacopeia (USP) Reference Standard

    1672803

    Transplatin, United States Pharmacopeia (USP) Reference Standard

    1134357

    Cisplatin, United States Pharmacopeia (USP) Reference Standard

    PHR1624

    Cisplatin, Pharmaceutical Secondary Standard; Certified Reference Material

    BP510

    Potassium trichloroammineplatinate, British Pharmacopoeia (BP) Reference Standard

    BP544

    Transplatin, British Pharmacopoeia (BP) Reference Standard

    PHR3252

    Transplatin, pharmaceutical secondary standard, certified reference material

    Pictograms

    Skull and crossbonesHealth hazard
    GHS06,GHS08

    Signal Word

    Danger

    Hazard Classifications

    Acute Tox. 2 Oral - Carc. 1B - Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3

    Target Organs

    Respiratory system

    Storage Class Code

    6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

    WGK

    WGK 3

    Flash Point(F)

    Not applicable

    Flash Point(C)

    Not applicable

    Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number

    Sorry, we don't have COAs for this product available online at this time.

    If you need assistance, please contact Customer Support.

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Ruiqian Li et al.
    International urology and nephrology, 52(1), 187-196 (2019-12-13)
    Cisplatin could result in a wide range of kidney injuries. During the pathogenetic process, the excessive generation of reactive oxygen species (ROS) induced by cisplatin has been regarded as the initial and critical role, by which DNA damage and cell
    Shihong Ma et al.
    Journal of cellular biochemistry, 121(5-6), 3256-3265 (2020-01-07)
    Aberrant activation of the Hedgehog (Hh)/Gli pathway contributes to the tumorigenesis of several human cancers, including ovarian cancers. We investigated the function of SMO on cell growth, drug resistance, and invasive ability in A2780/DDP cells. Moreover, we also tested the
    Teng Wang et al.
    Biochimica et biophysica acta. Molecular cell research, 1867(12), 118833-118833 (2020-08-30)
    Epithelial-mesenchymal transition (EMT) is considered as the key mechanism involved in cancer metastasis. Several studies showed that various cell membrane calcium channels play different roles in cancer metastasis. In the present study, the potential role of ATPase plasma membrane Ca2+
    Xiaochen Wang et al.
    Stem cells international, 2020, 8877577-8877577 (2020-09-05)
    Esophageal squamous cell carcinoma (ESCC) is a frequent malignant tumor with low 5-year overall survival. Targeting ESCC tumor-initiating cells (TICs) may provide a new research avenue to achieve better therapeutic effects of ESCC. However, the identity and characteristics of ESCC
    Lan Wang et al.
    Marine drugs, 18(10) (2020-10-01)
    Ascomylactam A was reported for the first time as a new 13-membered-ring macrocyclic alkaloid in 2019 from the mangrove endophytic fungus Didymella sp. CYSK-4 from the South China Sea. The aim of our study was to delineate the effects of
    View All Related Papers

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service